Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
Studio
Year-over-Year Change

Enterprise value to sales ratio

Percentile
P71
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20256.18-55.7%
202413.95-95.8%
2023331.24-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-